---
title: "EU MDR Readiness Check: Survey Results | Climedo Health"
description: EU-MDR most likely to be postponed by 12 months due to COVID-19. But would MedTech companies have been ready anyway?
image: https://discover.climedo.com/hubfs/Flatlay_MDR-EN.jpg
---

![Flatlay_MDR-EN](https://discover.climedo.com/hs-fs/hubfs/Flatlay_MDR-EN.jpg?width=2500&height=1574&name=Flatlay_MDR-EN.jpg "Flatlay_MDR-EN")

![logo_white_full](https://discover.climedo.com/hs-fs/hubfs/logo_white_full.png?width=3832&name=logo_white_full.png "logo_white_full")

# EU MDR Readiness Check: Full Survey Results

#### MDR postponed due to COVID-19 // Many MedTech companies not ready

There has been a lot of uncertainty surrounding the EU MDR (Medical Device Regulation (2017/745). Amidst the **COVID-19 Pandemic** and following requests by several European associations, the European Commission (EC) recently announced that it plans to **delay the deadline by one year**. The lack of Notified Bodies (as of March 2020, there were 12), and the fact that Coronavirus could cause significant bottlenecks in the MedTech market (e.g. if certain device certificates cannot be renewed on time) were just some of the reasons for the requested delay. The following survey results show how well prepared MedTech companies actually were for the MDR.

On February 26, 2020, we set out to assess the state of implementation of the EU MDR requirements among MedTech companies in Europe. Our EU MDR Readiness survey consisted of **14 questions** and closed on March 25, 2020. Although we have participants from all over Europe, the majority (86%) came from the German-speaking region. **110 companies** took part, most of them (85%) medical device manufacturers. 

Overall, the results show that **only few companies were ready** for the new regulation in terms of their Post-Market Surveillance, Quality Management Systems, Notified Bodies and clinical data capture systems:

- More than three quarters (**77%**) consider the new regulation to be "**very challenging**"
- The main challenges identified were "**lack of clarity** regarding the new requirements" and "**increased resources** and **costs**” 
- Around one third believe that EU MDR will cost more than **5% of their annual turnover**
- Only **26%** have a fully **MDR-compliant QMS**
- **34%** do not yet have a **Notified Body** or are currently switching NBs 
- **Almost half** do not (yet) have a **PMS plan**
- Many companies still use **paper** (**48%**) and/or **Excel spreadsheets** (**69%**) for clinical data collection (multiple selections possible)

We're curious to see what the coming year will bring for MedTech and hope that you will enjoy browsing through this slide deck. If you have any questions or feedback, please feel free to contact us at [hello@climedo.de](mailto:hello@climedo.de).

**About Climedo Health**

Climedo Health’s mission is to bring the best treatment to every patient by empowering healthcare professionals with intelligent software solutions.   
Together with Europe’s leading hospitals, they have developed a cloud-based platform for cutting-edge clinical validation of medical devices and pharmaceutical products. By digitally connecting all stakeholders (Medical Device manufacturers, Pharma companies, CROs, hospitals and patients), Climedo allows for increased performance, better cost-efficiencies - and ultimately - accelerated medical innovation. Learn more: [**www.climedo.com**.](http://www.climedo.com)